The importance of neurotropic vitamins in the prevention and adjuvant therapy of peripheral neuropathy – A pharmacist’s comprehensive view

Czech version

Authors: Ondřej Šimandl
Authors‘ workplace: Ústav farmakologie 2. lékařské fakulty Univerzity Karlovy, Praha ; EUC Lékárna, Poliklinika Malešice, Praha
Published in: Čes. slov. Farm., 2024; 73, 80-87
Category: Current Pharmacotherapy
doi: https://doi.org/10.36290/csf.2024.011

Overview

Peripheral neuropathy is one of the most common neurological diseases of the peripheral nervous system. According to current statistics, it affects 2.4% of the Czech population, and its prevalence continues to increase with age. The possibilities of its treatment are to a large extent limited, and its effectiveness and the patient‘s tolerance of pharmacotherapy are individual. Neurotropic vitamins, which support the function of neurons and contribute to their protection and regeneration, represent a promising possibility for prevention and use in adjuvant therapy for patients suffering from this disease. Despite the fact that the diagnosis and treatment of peripheral neuropathy belong to the doctor, the role of the pharmacist can be crucial not only in the area of ensuring effective and safe pharmacotherapy and adherence to it, but also in pre-screening of at-risk persons visiting pharmacies. The primary aim of the article is therefore to familiarize readers with the significance of neurotropic vitamins in the prevention and adjunct therapy of peripheral neuropathy, as well as the role of the pharmacist in the care of patients suffering from this condition.

Keywords:

Peripheral neuropathy – Pharmaceutical Care – neurotropic vitamins

Sources

1. England JD, Asbury AK. Peripheral neuropathy. Lancet [Internet]. 2004; 363(9427): 2151- 61. [cited 2024 March 24]. Available from: 10.1016/S0140-6736(04)16508-2.

2. van den Bergh PYK, van Doorn PA, Hadden RDM, et al. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force – Second revision. J Peripher Nerv Syst. [Internet]. 2021;26(3):242-268. [cited 2024 March 30]. Available from: 10.1111/jns.12455.

3. Ehler E. Periferní neuropatie v ambulantní praxi. Neurol. Pro praxi [Internet]. 2009;10(1):32- 36. [cited 2024 March 28]. Available from: https://www.neurologiepropraxi.cz/artkey/neu200901-0008_Periferni_neuropatie_v_ambulantni_praxi.php.

4. Rutkove SB. Overview of polyneuropathy. In: UpToDate [Internet]. 2022 Aug 23. [cited 2024 March 30]. Available from: https://www-uptodate-com.ezproxy.is.cuni.cz/contents/ overview-of-polyneuropathy/print?search=peripheral%20neuropathy&source=search_result&selectedTitle=1%7E150&usage_type=default&display_rank=1.

5. Alušík Š, Paluch Z. Léčivy indukované periferní neuropatie. Klin Farmakol Farm. [Internet]. 2014;28(3):112-116. [cited 2024 March 28]. Available from: https://www.klinickafarmakologie.cz/artkey/far-201403-0007_Lecivy_indukovane_periferni_neuropatie.php.

6. Tisdale JE, Miller DA. Drug-Induced Diseases, 3rd Edition. ASHP; 2018.

7. Klaassen CD (Ed.). Casarett & Doull's Toxicology: The Basic Science of Poisons, 9th edition. McGraw-Hill Education [Internet]. 2019. [cited 2024 March 30]. Available from: https://accesspharmacy.mhmedical.com/content.aspx?bookid=2462&sectionid=194917646.

8. Moser VC, Aschner M, Richardson JR, Bowman AB, Richardson RJ. Toxic Responses of the Nervous System. In: Klaassen CD, Watkins JB, III. eds. Casarett & Doull’s Essentials of Toxicology, 4e. McGraw Hill [Internet]. 2021. [cited 2024 March 30]. Available from: https:// accesspharmacy.mhmedical.com/content.aspx?bookid=3000&sectionid=252314425.

9. Ambler Z, Bednařík J, Keller O. Doporučený postup pro léčbu neuropatické bolesti. Česká neurologické společnost [Internet]. [cited 2024 March 28]. Available from: https://www. neuromuskularni-sekce.cz/index.php?pg=odborne-materialy--doporuceny-postup-pro- -lecbu-neuropaticke-bolesti.

10. Bednařík J, Ambler Z, Opavský J, et al. Klinický standard pro farmakoterapii neuropatické bolesti (verze 1.0). Národní referenční centrum [Internet]. 2011. [cited 2024 March 28]. Available from: https://www.neuromuskularni-sekce.cz/res/file/0029_npbol_pub_1_0.pdf.

11. Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. European Journal of Neurology [Internet]. 2010;17:1113- 1123. [cited 2024 March 28]. Available from: 10.1111/j.1468-1331.2010.02999.x.

12. Rajdová A, Vlčková E. Farmakoterapie neuropatické bolesti v dospělém věku. Neurol. praxi [Internet]. 2020;21(5):373-377. [cited 2024 March 28]. Available from: 10.36290/ neu.2020.092.

13. Lacigová S, Rušavý Z, Jirkovská A, Škrha J. Doporučený postup diagnostiky a léčby diabetické neuropatie (2016). Česká diabetologická společnost. DMEV [Internet]. 2016;2(19):57-63. [cited 2024 March 30]. Available from: https://www.diab.cz/dokumenty/standardy_neuropatie.pdf.

14. Otruba P. Periferní neuropatie – diagnostika a léčba v ordinaci praktického lékaře. Klinická diagnostika Med. Praxi [Internet]. 2011;8(6):285-287. [cited 2024 March 30]. Available from: https://www.medicinapropraxi.cz/artkey/med-201106-0008_Periferni_neuropatie- -diagnostika_a_lecba_v_ordinaci_praktickeho_lekare.php.

15. Baltrusch S. The Role of Neurotropic B Vitamins in Nerve Regeneration. Biomed Res Int. [Internet]. 2021; s. 1–9. [cited 2024 March 30]. Available from: 10.1155/2021/9968228.

16. Kasper H. Výživa v medicíně a dietetika. Praha: Grada; 2015.

17. Sobotka L. Vitaminy. Interní Med. [Internet]. 2003;5(2):61-67. [cited 2024 March 30]. Available from: https://www.internimedicina.cz/artkey/int-200302-0004_Vitaminy.php.

18. Pazirandeh S, Burns DL. Overview of water-soluble vitamins. In: UpToDate [Internet]. 2023 Jun 23. [cited 2024 March 30]. Available from: https://www-uptodate-com.ezproxy.is.cuni.cz/contents/overview-of-water-soluble-vitamins?search=vitamin%20b&topicRef=5368&source=see_link.

19. P&G Health. Nurobion – edukační materiál. Proctor & Gamble Czech Republic s.r.o. MAT-CZ-NEUROBION-23-000002 20. Gibson GE, Zhang H. Interactions of oxidative stress with thiamine homeostasis promote neurodegeneration. Neurochem Int. [Internet]. 2002;40(6):493-504. [cited 2024 March 30]. Available from: 10.1016/s0197-0186(01)00120-6.

20. Gibson GE, Zhang H. Interactions of oxidative stress with thiamine homeostasis promote neurodegeneration. Neurochem Int. [Internet]. 2002;40(6):493-504. [cited 2024 March 30]. Available from: 10.1016/s0197-0186(01)00120-6.

21. Wang XD, Kashii S, Zhao L, Tonchev AB, Katsuki H, Akaike A, Honda Y, Yamashita J, Yamashima T. Vitamin B6 protects primate retinal neurons from ischemic injury. Brain Res. [Internet]. 2002;940(1–2):36-43. [cited 2024 March 30]. Available from: 10.1016/s0006- 8993(02)02587-8.

22. Liao WC, Chen JR, Wang YJ, Tseng GF. Methylcobalamin, but not methylprednisolone or pleiotrophin, accelerates the recovery of rat biceps after ulnar to musculocutaneous nerve transfer. Neuroscience [Internet]. 2010;171(3):934-949. [cited 2024 March 30]. Available from: 10.1016/j.neuroscience.2010.09.036.

23. Stabler SP. Vitamin B12 deficiency. N Engl J Med. [Internet]. 2013;368(21):2041-2. [cited 2024 March 30]. Available from: 10.1056/NEJMcp1113996.

24. Státní ústav pro kontrolu léčiv. Neurobion: Souhrn údajů o přípravku [Internet]. [cited 2024 March 30]. Available from: https://prehledy.sukl.cz/prehledy/v1/dokumenty/64748.

25. Howden CW. Vitamin B12 levels during prolonged treatment with proton pump inhibitors. J Clin Gastroenterol. [Internet]. 2000; 30(1):29-33. [cited 2024 March 29]. Available from: 10.1097/00004836-200001000-00006.

26. Kim J, Ahn CW, Fang S, Lee HS, Park JS. Association between metformin dose and vitamin B12 deficiency in patients with type 2 diabetes. Medicine (Baltimore) [Internet]. 2019; 98(46): e17918. [cited 2024 March 29]. Available from: 10.1097/MD.0000000000017918.

27. Ko SH, Ko S-H, Ahm YB, et al. Association of vitamin B12 deficiency and metformin use in patients with type 2 diabetes. J Korean Med Sci. [Internet]. 2014;29(7):965-72. [cited 2024 March 29]. Available from: 10.3346/jkms.2014.29.7.965.

28. American Diabetes Association. Standards of Care in Diabetes – 2023 Abridged for Primary Care Providers. Clin Diabetes [Internet]. 2023;41(1):4-31. [cited 2024 March 30]. Available from: 10.2337/cd23-as01.

29. Infante M, Leoni M, Caprio M, Fabbri A. Long-term metformin therapy and vitamin B12 deficiency: An association to bear in mind. World J Diabetes [Internet]. 2021;12(7) 916-931. [cited 2024 March 30]. Available from: 10.4239/wjd.v12.i7.916.

30. Sanz-Cuesta T, Escortell-Mayor E, Cura-Gonzalez, et al. Oral versus intramuscular administration of vitamin B12 for vitamin B12 deficiency in primary care: a pragmatic, randomised, non-inferiority clinical trial (OB12). BMJ Open [Internet]. 2020;10(8):e033687. [cited 2024 March 30]. Available from: 10.1136/bmjopen-2019-033687.

31. Státní ústav pro kontrolu léčiv. Milgamma N: Souhrn údajů o přípravku [Internet]. [cited 2024 March 30]. Available from: https://prehledy.sukl.cz/prehledy/v1/dokumenty/11950.

32. Státní ústav pro kontrolu léčiv. Neuromax Forte: Souhrn údajů o přípravku [Internet]. [cited 2024 March 30]. Available from: https://prehledy.sukl.cz/prehledy/v1/dokumenty/11972.

33. Státní ústav pro kontrolu léčiv. Neuromultivit: Souhrn údajů o přípravku [Internet]. [cited 2024 March 30]. Available from: https://prehledy.sukl.cz/prehledy/v1/dokumenty/60406.

34. Vinšová J, Hojdarová M. Možnosti farmaceutické péče o pacienty s neuropatickou bolestí. Prakt. lékáren. [Internet]. 2015;11(1):19-22. [cited 2024 March 30]. Available from: https://www.solen.cz/artkey/lek-201501-0006_Moznosti_farmaceuticke_pece_o_pacienty_s_neuropatickou_bolesti.php."

35. Bažantová M, Gregor S, Hojný M, et al. Doporučený postup pro výdej léčivých přípravků vázaných na lékařský předpis. Česká lékárnická komora. [Internet]. 2020. [cited 2024 March 30]. Available from: https://lekarnici.cz/wp-content/uploads/2022/12/dp-pro-vydej-lecivych-pripravku-vazanych-na-lekarsky-predpis-aktualizace-2020(1).pdf.